Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy	B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Active, not recruiting	Not stated	2026-06-09		NCT04282811
Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, myeloproliferative neoplasm	Active, not recruiting	Not stated	2025-09-23		NCT04378855
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)	High-risk MDS	Recruiting	Phase 3	2025-04-29		NCT04184505
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients	Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome	Recruiting	Not applicable	2024-10-22		NCT04587856
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Active, not recruiting	Phase 2	2024-10-22		NCT04475731